323 related articles for article (PubMed ID: 20370548)
1. Monitoring and assessing vaccine safety: a European perspective.
Lopalco PL; Johansen K; Ciancio B; De Carvalho Gomes H; Kramarz P; Giesecke J
Expert Rev Vaccines; 2010 Apr; 9(4):371-80. PubMed ID: 20370548
[TBL] [Abstract][Full Text] [Related]
2. Vaccinovigilance in Europe--need for timeliness, standardization and resources.
Lankinen KS; Pastila S; Kilpi T; Nohynek H; Mäkelä PH; Olin P
Bull World Health Organ; 2004 Nov; 82(11):828-35. PubMed ID: 15640918
[TBL] [Abstract][Full Text] [Related]
3. The Vaccine Safety Datalink: a model for monitoring immunization safety.
Baggs J; Gee J; Lewis E; Fowler G; Benson P; Lieu T; Naleway A; Klein NP; Baxter R; Belongia E; Glanz J; Hambidge SJ; Jacobsen SJ; Jackson L; Nordin J; Weintraub E
Pediatrics; 2011 May; 127 Suppl 1():S45-53. PubMed ID: 21502240
[TBL] [Abstract][Full Text] [Related]
4. Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.
LaRussa PS; Edwards KM; Dekker CL; Klein NP; Halsey NA; Marchant C; Baxter R; Engler RJ; Kissner J; Slade BA
Pediatrics; 2011 May; 127 Suppl 1():S65-73. PubMed ID: 21502239
[TBL] [Abstract][Full Text] [Related]
5. [Essential to monitor vaccine safety].
Heijbel H
Lakartidningen; 2001 Sep; 98(36):3777-8. PubMed ID: 11586806
[TBL] [Abstract][Full Text] [Related]
6. Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS.
;
Expert Rev Vaccines; 2009 Jun; 8(6):705-16. PubMed ID: 19485752
[TBL] [Abstract][Full Text] [Related]
7. What is vaccine advocacy? Proposal for a definition and action.
Balinska MA
Vaccine; 2004 Mar; 22(11-12):1335-42. PubMed ID: 15063555
[TBL] [Abstract][Full Text] [Related]
8. Safety monitoring in vaccine development and immunization.
Lee CJ; Lee LH; Lu CH; Huang YJ; Chu ML
Acta Paediatr Taiwan; 2006; 47(1):7-13. PubMed ID: 17016963
[TBL] [Abstract][Full Text] [Related]
9. Methods of ensuring vaccine safety.
Ball R
Expert Rev Vaccines; 2002 Aug; 1(2):161-8. PubMed ID: 12901555
[TBL] [Abstract][Full Text] [Related]
10. The development of standardized case definitions and guidelines for adverse events following immunization.
Kohl KS; Gidudu J; Bonhoeffer J; Braun MM; Buettcher M; Chen RT; Drammeh B; Duclos P; Heijbel H; Heininger U; Hummelman E; Jefferson T; Keller-Stanislawski B; Loupi E; Marcy SM
Vaccine; 2007 Aug; 25(31):5671-4. PubMed ID: 17400339
[No Abstract] [Full Text] [Related]
11. [Surveillance of secondary effects of vaccination].
Duclos P
Sante; 1994; 4(3):215-20. PubMed ID: 7921691
[TBL] [Abstract][Full Text] [Related]
12. The complicated task of monitoring vaccine safety.
Ellenberg SS; Chen RT
Public Health Rep; 1997; 112(1):10-20; discussion 21. PubMed ID: 9018282
[TBL] [Abstract][Full Text] [Related]
13. Developing a national system for dealing with adverse events following immunization.
Mehta U; Milstien JB; Duclos P; Folb PI
Bull World Health Organ; 2000; 78(2):170-7. PubMed ID: 10743281
[TBL] [Abstract][Full Text] [Related]
14. Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007.
Niu MT; Ball R; Woo EJ; Burwen DR; Knippen M; Braun MM;
Vaccine; 2009 Jan; 27(2):290-7. PubMed ID: 18992783
[TBL] [Abstract][Full Text] [Related]
15. Surveillance of adverse effects following vaccination and safety of immunization programs.
Waldman EA; Luhm KR; Monteiro SA; Freitas FR
Rev Saude Publica; 2011 Feb; 45(1):173-84. PubMed ID: 21181055
[TBL] [Abstract][Full Text] [Related]
16. Field evaluation of vaccine safety.
Tozzi AE
Vaccine; 2004 May; 22(15-16):2091-5. PubMed ID: 15121330
[TBL] [Abstract][Full Text] [Related]
17. Postlicensure epidemiology of childhood vaccination: the Danish experience.
Hviid A
Expert Rev Vaccines; 2006 Oct; 5(5):641-9. PubMed ID: 17181438
[TBL] [Abstract][Full Text] [Related]
18. Postmarketing modifications in the safety labeling of the new antiepileptics.
Buck ML; Gurka MJ; Goodkin HP
Neurology; 2007 May; 68(18):1536-7. PubMed ID: 17470758
[No Abstract] [Full Text] [Related]
19. [Adverse events after vaccination].
Nøkleby H; Bergsaker MA
Tidsskr Nor Laegeforen; 2006 Oct; 126(19):2541-4. PubMed ID: 17028637
[TBL] [Abstract][Full Text] [Related]
20. The Vaccine Safety Datalink project.
DeStefano F;
Pharmacoepidemiol Drug Saf; 2001; 10(5):403-6. PubMed ID: 11802585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]